Oxymetazoline nasal spray improved nCPAP compliance in obstructive sleep apnea-hypopnea syndrome patients with nasal obstruction

Wei LUO,Xu-ping WANG,Zhen-yu CHEN,Jia ZHANG,Lin WU,Fei HE,Pei-jie WANG,Gan WANG,Hong HAO
DOI: https://doi.org/10.6040/j.issn.1673-3770.0.2013.303
2014-01-01
Abstract:Objective To evaluate the effectiveness of oxymetazoline nasal spray in the treatment of obstructive sleep apnea-hypopnea syndrome (OSAHS)patients with nasal obstruction by nasal continuous positive airway pressure(nC-PAP)therapy.Methods 60patientsdiagnosedasmoderatetosevereOSAHSwithnasalobstructionunderwentafive-night nCPAP therapy.They were ramandly divided into oxymetazoline therapy group and non-oxymetazoline therapy group before using nCPAP.The ESS score and the differences of effective nCPAP pressure before and after oxymetazo-line therapy were analyzed.Results The ESS score were significant reduced after oxymetazoline therapy,with a sig-nificant decreased effective treatment pressure.Conclusion Oxymetazoline nasal spray can reduce nCPAP pressure in the treatment of OSAHS patients with nasal obstruction.nCPAP compliance could be improved due to the reduction of the pressure.
What problem does this paper attempt to address?